Immune regulation by CD4+CD25+ regulatory T cells: implications for transplantation tolerance

被引:33
作者
Taams, L
Vukmanovic-Stejic, M
Salmon, M
Akbar, A
机构
[1] UCL Royal Free & Univ Coll Med Sch, Windeyer Inst Med Sci, Dept Immunol & Mol Pathol, London W1T 4JF, England
[2] Infect & Immun Res Grp, London SE1 9NN, England
[3] Univ Birmingham, MRC Ctr Immune Regulat, Dept Rheumatol, Birmingham B15 2TT, W Midlands, England
关键词
immune regulation; tolerance; anergy; suppression;
D O I
10.1016/S0966-3274(03)00047-9
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
In transplantation research, the achievement of life-long tolerance for the graft without the need for immunosuppressive drugs, is a major goal. In the immune system various mechanisms are in place that help to prevent unwanted immunity. These mechanisms of peripheral tolerance include deletion, anergy, ignorance and suppression. In the last decade it has been demonstrated convincingly that a naturally occurring subset of CD4+ T cells, the so-called CD4+ CD25+ regulatory T cells, play a key role in the suppression/regulation of immune responses. These cells have been shown to exist in mice, rats and humans, and can be found in thymus, peripheral blood, lymphoid organs and at sites of inflammation. CD4+CD25+ regulatory T cells can down-regulate the immune response by affecting T cell responses, antibody production, cytokine secretion and antigen-presenting cells. CD4+CD25+ regulatory T cells are generated in the thymus, but importantly recent evidence suggests that they can also be generated in the periphery. This latter finding is of particular importance for transplantation immunology, since it suggests that specific manipulation or induction of these cells is achievable in vivo. Here we review the recent developments on the CD4+ CD25+ regulatory T cells and we discuss the potential use of these cells in transplantation immunology. (C) 2003 Elsevier B.V. All rights reserved.
引用
收藏
页码:277 / 285
页数:9
相关论文
共 81 条
[1]   CD25+ CD4+ T cells regulate the expansion of peripheral CD4 T cells through the production of IL-10 [J].
Annacker, O ;
Pimenta-Araujo, R ;
Burlen-Defranoux, O ;
Barbosa, TC ;
Cumano, A ;
Bandeira, A .
JOURNAL OF IMMUNOLOGY, 2001, 166 (05) :3008-3018
[2]   Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation [J].
Asano, M ;
Toda, M ;
Sakaguchi, N ;
Sakaguchi, S .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (02) :387-396
[3]   Inhibition of human CD4+CD25+high regulatory T cell function [J].
Baecher-Allan, C ;
Viglietta, V ;
Hafler, DA .
JOURNAL OF IMMUNOLOGY, 2002, 169 (11) :6210-6217
[4]   CD4+CD25high regulatory cells in human peripheral blood [J].
Baecher-Allan, C ;
Brown, JA ;
Freeman, GJ ;
Hafler, DA .
JOURNAL OF IMMUNOLOGY, 2001, 167 (03) :1245-1253
[5]   In vitro generation of interleukin 10-producing regulatory CD4+ T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines [J].
Barrat, FJ ;
Cua, DJ ;
Boonstra, A ;
Richards, DF ;
Crain, C ;
Savelkoul, HF ;
de Waal-Malefyt, R ;
Coffman, RL ;
Hawrylowicz, CM ;
O'Garra, A .
JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 195 (05) :603-616
[6]   CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity [J].
Belkaid, Y ;
Piccirillo, CA ;
Mendez, S ;
Shevach, EM ;
Sacks, DL .
NATURE, 2002, 420 (6915) :502-507
[7]   Major histocompatibility complex class II-positive cortical epithelium mediates the selection of CD4+25+ immunoregulatory T cells [J].
Bensinger, SJ ;
Bandeira, A ;
Jordan, MS ;
Caton, AJ ;
Laufer, TM .
JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 194 (04) :427-438
[8]   Regulatory T cells selectively express toll-like receptors and are activated by lipopolysaccharide [J].
Caramalho, I ;
Lopes-Carvalho, T ;
Ostler, D ;
Zelenay, S ;
Haury, M ;
Demengeot, J .
JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 197 (04) :403-411
[9]  
Cederbom L, 2000, EUR J IMMUNOL, V30, P1538, DOI 10.1002/1521-4141(200006)30:6<1538::AID-IMMU1538>3.0.CO
[10]  
2-X